ABL Diagnostics Files Takeover Bid to Acquire IntegraGen
September 11, 2026
ABL Diagnostics (ABLD) announced it filed a takeover bid to acquire IntegraGen’s business operations and assets. The target is currently subject to judicial reorganization proceedings before the Commercial Court of Évry, and the bid remains subject to the court’s decision and selection as successful bidder.
- Buyers
- ABL Diagnostics (ABLD)
- Targets
- IntegraGen
- Industry
- Healthcare Services
- Location
- France
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
ABL Diagnostics Selected by Évry Commercial Court to Acquire TEXCELL’s Operations
July 24, 2026
Healthcare Services
ABL Diagnostics said it has been selected by the Évry Commercial Court to acquire the assets and business operations of TEXCELL. The deal involves the transfer of 29 employees and the continuation of TEXCELL’s operations at the Genopole site in Évry-Courcouronnes, strengthening ABL Diagnostics’ virology and biosafety capabilities for biopharmaceutical customers.
-
ABL Group to Acquire SynergenOG
May 14, 2026
IT Services
ABL Group announced it has signed an agreement to acquire 100% of the shares in SynergenOG. Following completion, SynergenOG will be integrated into Longitude, ABL Group’s design and engineering division, to expand process safety and technical risk management capabilities for the energy sector.
-
LabGenomics USA Acquires Integrated Molecular Diagnostics (IMD) CLIA Labs
October 25, 2024
Healthcare Services
LabGenomics USA acquired Integrated Molecular Diagnostics (IMD) CLIA labs, expanding its U.S. footprint to four CLIA-certified laboratories and strengthening its molecular and oncology diagnostic capabilities. The deal broadens LabGenomics' geographic reach across the U.S. coasts and positions the company to launch new laboratory-developed tests (LDTs) and expand reimbursable services.
-
Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)
October 4, 2022
Biotechnology
Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.
-
Fulgent Genetics Acquires Inform Diagnostics from Avista Capital Partners
April 18, 2022
Healthcare Services
Fulgent Genetics (NASDAQ: FLGT) closed its acquisition of Inform Diagnostics, a national independent pathology laboratory headquartered in Irving, Texas, for approximately $170 million (subject to adjustments). Avista Capital Partners had carved out and grown Inform Diagnostics before selling it to Fulgent, enabling Fulgent to expand into pathology test menus and nationwide commercial infrastructure.
-
Integra LifeSciences Acquires ACell, Inc.
December 16, 2020
Medical Devices
Integra LifeSciences agreed to acquire regenerative-medicine company ACell, Inc. for $300 million upfront in cash plus up to $100 million in revenue-based milestones. The acquisition adds ACell's MatriStem porcine urinary bladder matrix platform to Integra's tissue technologies portfolio and is expected to close in Q1 2021, subject to customary conditions.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.